Repligen
RGEN
#2575
Rank
C$9.24 B
Marketcap
C$164.10
Share price
-0.46%
Change (1 day)
-0.76%
Change (1 year)
Categories

Repligen (RGEN) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : C$1.17 Billion

According to Repligen 's latest financial reports the company's total liabilities are C$1.17 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Repligen - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31C$1.15 B-6.06%
2024-12-31C$1.22 B7.02%
2023-12-31C$1.14 B36.38%
2022-12-31C$0.84 B8.68%
2021-12-31C$0.77 B62.68%
2020-12-31C$0.47 B7.21%
2019-12-31C$0.44 B105.16%
2018-12-31C$0.21 B13.4%
2017-12-31C$0.19 B18.33%
2016-12-31C$0.16 B395.53%
2015-12-31C$32.58 M69.54%
2014-12-31C$19.21 M22.33%
2013-12-31C$15.71 M22.61%
2012-12-31C$12.81 M
2011-03-31C$5.04 M-5.5%
2010-03-31C$5.34 M-8.28%
2009-03-31C$5.82 M21.36%
2008-03-31C$4.8 M17.23%
2007-03-31C$4.09 M9.92%
2006-03-31C$3.72 M-7.46%
2005-03-31C$4.02 M25.64%
2004-03-31C$3.2 M-2.76%
2003-03-31C$3.29 M-22.55%
2002-03-31C$4.25 M114.49%
2001-03-31C$1.98 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
C$169.12 B 14,289.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
C$79.14 B 6,634.12%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
C$155.03 B 13,090.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$99.66 B 8,379.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
C$0.11 B-90.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
C$1.81 B 54.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$1.92 B 63.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
C$0.71 B-39.34%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$2.09 B 78.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
C$5.46 B 365.19%๐Ÿ‡บ๐Ÿ‡ธ USA